Stay updated on Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial
Sign up to get notified when there's something new on the Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial page.

Latest updates to the Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedAdded a new revision (v3.5.0) to the Record History, replacing the previous v3.4.3 entry to reflect an updated study record.SummaryDifference0.1%

- Check19 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed from the study record history.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check47 days agoChange DetectedRevision: v3.4.2 was added; the government-funding notice and the v3.4.1 entry were removed.SummaryDifference0.7%

- Check55 days agoChange DetectedA site-wide notice about government funding lapse and updated status was added, and the history shows Release Revision: v3.4.1 with v3.4.0 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check62 days agoChange DetectedNew version introduces UI updates: a Show glossary option and color-coded highlights to distinguish additions and deletions, along with a Revision: v3.4.0 header. The No FEAR Act Data label is updated.SummaryDifference0.9%

- Check76 days agoChange DetectedThe history shows a new revision entry (v3.3.4) and removal of v3.3.3, which are metadata changes to the record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial page.